SkyQuest Technology Group recently introduced Empty Capsules Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Empty Capsules Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Global Empty Capsules Market size was valued at USD 3.6 Billion in 2023 and is poised to grow from USD 3.82 Billion in 2024 to USD 6.19 Billion by 2032, growing at a CAGR of 6.2% during the forecast period (2025-2032).
More customers are selecting capsules over tablets because they are simpler to swallow and dissolve faster. The strong demand for capsules in the pharmaceutical, nutraceutical, and cosmeceutical industries is also propelling the empty capsules market growth.
Many customers prefer capsules because they dissolve quickly and allow for faster absorption. The tasteless and odorless gelatin coating of these capsules makes them more palatable as well. Encapsulated medications increase the bioavailability of certain active ingredients by shielding them from the harsh conditions of the gastrointestinal tract.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/empty-capsules-market
The 2025 global Empty Capsules Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Empty Capsules Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Empty Capsules Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
The global empty capsules market is segmented into product, functionality, therapeutic application, end user, and region.
By product, the market is bifurcated into gelatin capsules and non-gelatin capsules.
Depending on functionality, it is divided into immediate-release capsules, delayed-released capsules, and sustained/extended- release capsules.
According to the therapeutic application, the market is classified into antibiotic & antibacterial, vitamins & dietary supplements, antacid & antiflatulent, and cardiovascular therapy.
As per end user it is categorized into pharmaceutical industry, nutraceutical industry, cosmetic & personal care, and research & academic laboratories.
Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Empty Capsules Market – Regional Analysis:
As per the empty capsules market regional analysis, North America led the market in 2024 because of its strong pharmaceutical R&D and high supplement consumption. For example, in response to the increasing demand for plant-based capsules, Lonza increased its production in the United States.
Asia-Pacific is the region with the fastest rate of development due to innovation-driven demand in South Korea and Japan, as well as hubs for capsule manufacturing in China and India. In 2025, Suheung (South Korea) expanded its production of gelatin capsules worldwide by collaborating with Indian suppliers. Demand in the pharmaceutical and nutraceutical industries in the region has been further increased by the popularity of herbal capsules and government assistance for the export of generic drugs.
Europe remains the world leader in capsule customization because of strict regulations and a preference for clean labels. Dual-release capsules for supplements with several ingredients were first made available in Spain in 2024 by Qualicaps Europe. The pharmaceutical and nutraceutical industries on the continent are expected to grow gradually because of the rising demand for encapsulated botanicals in Germany and France, as well as the popularity of vegan, gluten-free, and low-allergen formulations.
Top Market Players in Empty Capsules Market are:
Lonza Group (Capsugel)
ACG Worldwide
Qualicaps
Suheung Co. Ltd.
HealthCaps India Ltd.
CapsCanada
Sunil Healthcare Ltd.
Roxlor LLC
Snail Pharma Industry Co., Ltd.
Pharmaphil Inc.
Natural Capsules Ltd.
Suhai Capsules
Hovione
Roquette
For a customized report, contact us to request personalization – https://www.skyquestt.com/speak-with-analyst/empty-capsules-market
Recent Developments in Empty Capsules Market:
In January 2025, Roquette paid USD 2.85 billion to acquire IFF Pharma Solutions in order to strengthen its position in the global pharmaceutical and nutraceutical markets, enhance its excipient capabilities, and advance oral-dosage technologies.
In January 2025, Hovione and Zerion Pharma established a joint venture to commercialize Dispersome technology, which aims to improve bioavailability in respiratory drug and nutraceutical applications in Europe, the US, and emerging Asian markets.
In March 2024, Lonza and Roche declared their intention to purchase Genentech’s biologics manufacturing plant in California for over USD 1 billion USD. This is expected to significantly increase Lonza’s ability to produce biologics and place it among the largest sites globally. Lonza plans to invest nearly USD 600 million to upgrade the facility and expand its capabilities in order to meet the demands of next-generation mammalian biologics therapies.
Take Action Now: Secure Your Empty Capsules Market Today – https://www.skyquestt.com/buy-now/empty-capsules-market
Forward-Looking Insights
The Empty Capsules Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
